253 related articles for article (PubMed ID: 33895079)
1. The evolving landscape of untargeted metabolomics.
Di Minno A; Gelzo M; Stornaiuolo M; Ruoppolo M; Castaldo G
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1645-1652. PubMed ID: 33895079
[TBL] [Abstract][Full Text] [Related]
2. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
Cui L; Lu H; Lee YH
Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
[TBL] [Abstract][Full Text] [Related]
3. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
[TBL] [Abstract][Full Text] [Related]
4. Untargeted Metabolomics Strategies-Challenges and Emerging Directions.
Schrimpe-Rutledge AC; Codreanu SG; Sherrod SD; McLean JA
J Am Soc Mass Spectrom; 2016 Dec; 27(12):1897-1905. PubMed ID: 27624161
[TBL] [Abstract][Full Text] [Related]
5. After the feature presentation: technologies bridging untargeted metabolomics and biology.
Cho K; Mahieu NG; Johnson SL; Patti GJ
Curr Opin Biotechnol; 2014 Aug; 28():143-8. PubMed ID: 24816495
[TBL] [Abstract][Full Text] [Related]
6. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
7. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
Di Minno A; Gelzo M; Caterino M; Costanzo M; Ruoppolo M; Castaldo G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563604
[TBL] [Abstract][Full Text] [Related]
8. Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome.
Hsu YH; Astley CM; Cole JB; Vedantam S; Mercader JM; Metspalu A; Fischer K; Fortney K; Morgen EK; Gonzalez C; Gonzalez ME; Esko T; Hirschhorn JN
Int J Obes (Lond); 2020 Jul; 44(7):1596-1606. PubMed ID: 32467615
[TBL] [Abstract][Full Text] [Related]
9. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics for laboratory diagnostics.
Bujak R; Struck-Lewicka W; Markuszewski MJ; Kaliszan R
J Pharm Biomed Anal; 2015 Sep; 113():108-20. PubMed ID: 25577715
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing.
Kennedy AD; Wittmann BM; Evans AM; Miller LAD; Toal DR; Lonergan S; Elsea SH; Pappan KL
J Mass Spectrom; 2018 Nov; 53(11):1143-1154. PubMed ID: 30242936
[TBL] [Abstract][Full Text] [Related]
12. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
[TBL] [Abstract][Full Text] [Related]
13. Assessment of coverage for endogenous metabolites and exogenous chemical compounds using an untargeted metabolomics platform.
Kong SW; Hernandez-Ferrer C
Pac Symp Biocomput; 2020; 25():587-598. PubMed ID: 31797630
[TBL] [Abstract][Full Text] [Related]
14. Application of Metabolomics in Lung Research.
Reisdorph NA; Cruickshank-Quinn C; Nkrumah-Elie Y; Reisdorph R
Methods Mol Biol; 2018; 1809():263-288. PubMed ID: 29987794
[TBL] [Abstract][Full Text] [Related]
15. Challenges in mass spectrometry based targeted metabolomics.
Koal T; Deigner HP
Curr Mol Med; 2010 Mar; 10(2):216-26. PubMed ID: 20196726
[TBL] [Abstract][Full Text] [Related]
16. Gender-related metabolomics and lipidomics: From experimental animal models to clinical evidence.
Audano M; Maldini M; De Fabiani E; Mitro N; Caruso D
J Proteomics; 2018 Apr; 178():82-91. PubMed ID: 29122727
[TBL] [Abstract][Full Text] [Related]
17. Multiplatform untargeted metabolomics.
Jeppesen MJ; Powers R
Magn Reson Chem; 2023 Dec; 61(12):628-653. PubMed ID: 37005774
[TBL] [Abstract][Full Text] [Related]
18. Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.
García A; Godzien J; López-Gonzálvez Á; Barbas C
Bioanalysis; 2017 Jan; 9(1):99-130. PubMed ID: 27921456
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic network analysis of estrogen-stimulated MCF-7 cells: a comparison of overrepresentation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis.
Maertens A; Bouhifd M; Zhao L; Odwin-DaCosta S; Kleensang A; Yager JD; Hartung T
Arch Toxicol; 2017 Jan; 91(1):217-230. PubMed ID: 27039105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
